Cite
Howard TP, Oberlick EM, Rees MG, et al. Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine. Clin Cancer Res. 2020;26(18):4995-5006doi: 10.1158/1078-0432.CCR-19-2717.
Howard, T. P., Oberlick, E. M., Rees, M. G., Arnoff, T. E., Pham, M. T., Brenan, L., DoCarmo, M., Hong, A. L., Kugener, G., Chou, H. C., Drosos, Y., Mathias, K. M., Ramos, P., Seashore-Ludlow, B., Giacomelli, A. O., Wang, X., Freeman, B. B., Blankenship, K., Hoffmann, L., Tiv, H. L., Gokhale, P. C., Johannessen, C. M., Stewart, E. A., Schreiber, S. L., Hahn, W. C., & Roberts, C. W. M. (2020). Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(18), 4995-5006. https://doi.org/10.1158/1078-0432.CCR-19-2717
Howard, Thomas P, et al. "Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26,18 (2020): 4995-5006. doi: https://doi.org/10.1158/1078-0432.CCR-19-2717
Howard TP, Oberlick EM, Rees MG, Arnoff TE, Pham MT, Brenan L, DoCarmo M, Hong AL, Kugener G, Chou HC, Drosos Y, Mathias KM, Ramos P, Seashore-Ludlow B, Giacomelli AO, Wang X, Freeman BB, Blankenship K, Hoffmann L, Tiv HL, Gokhale PC, Johannessen CM, Stewart EA, Schreiber SL, Hahn WC, Roberts CWM. Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine. Clin Cancer Res. 2020 Sep 15;26(18):4995-5006. doi: 10.1158/1078-0432.CCR-19-2717. Epub 2020 Jul 06. PMID: 32631955; PMCID: PMC7501142.
Copy
Download .nbib